Evgeniy V. Gorbachev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evgeniy V. Gorbachev has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Evgeny Dmitrievich Fedorov
N.I. Pirogov Russian National Research Medical University; City Clinical Hospital No. 31 named after Academician G.M. Savelyeva
8 shared publications - Valeria O. Kaibysheva
N.I. Pirogov Russian National Research Medical University
6 shared publications - Sergey G. Shapovalyants
N.I. Pirogov Russian National Research Medical University ; City Clinical Hospital No. 31 named after Academician G.M. Saveleyevа, Moscow City Health Department
4 shared publications - A. I. Mokritskiy
N.I. Pirogov Russian National Research Medical University
3 shared publications - Lyudmila Mikhaylovna Mikhaleva
Petrovsky National Research Centre of Surgery, Moscow, Russia
3 shared publications K. S. Maslyonkina
Petrovsky National Research Center of Surgery
2 shared publications
Latest Publications
- Open Access
- 5 September 2026
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 36 (4) , 55-66
Biological Therapy for Complicated Forms of Eosinophilic Esophagitis
Aim: to evaluate the efficacy and safety of dupilumab, a biologic therapy, in the treatment of refractory eosinophilic esophagitis complicated by esophageal strictures and food impaction, in patients who have failed prior therapy with proton pump inhibitors and topical glucocorticosteroids. Materials and methods. In a prospective study conducted from July 2024 to February 2026, 19 patients (2 females, 17 males) aged 19 to 70 years with a previously confirmed diagnosis of eosinophilic esophagitis were administered dupilumab at a dose of 300 mg once weekly subcutaneously for 12 weeks. Indications for dupilumab administration included a complicated disease course (esophageal strictures and narrowing, esophageal dissection, recurrent episodes of acute food impaction) in the setting of resistance to prior therapy with topical glucocorticosteroids and/or proton pump inhibitors. Additional criteria for initiating biologic therapy included coexisting T2-associated diseases, such as bronchial asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. All patients underwent assessment of dysphagia severity according to the Dysphagia Symptom Questionnaire (DSQ), calculation of the clinical and morphological disease activity index, esophagogastroduodenoscopy with esophageal biopsy (at least 6 biopsy specimens from the distal and middle/proximal esophagus), and histopathological examination of biopsy specimens both prior to treatment and at 12 weeks of therapy. Results. At 12 weeks of dupilumab therapy, complete resolution of dysphagia was observed in 9 (75 %) of 12 patients with dysphagia at baseline, and clinical remission (absence of any complaints) was achieved in 12 (63.2 %) of 19 patients. The mean DSQ score, reflecting dysphagia severity, decreased from 32.01 to 7.12 (p < 0.05). Endoscopic disease activity, as assessed by the EREхFS score, decreased from 5.0 [4.0; 7.0] to 1.0 [1.0; 3.0] points (p < 0.0001). Although the proportion of patients with strictures did not change significantly, an increase in esophageal diameter at the stricture site was observed (from 13.1 ± 5.8 mm to 16.1 ± 2.0 mm; p < 0.05). Histological remission (< 15 eosinophils per HPF, ×400) was achieved in 18 (94.7 %) of 19 patients. Adverse events included upper extremity joint pain (1 patient, 5.3 %), conjunctival dryness (2 patients, 10.5 %), and peripheral blood eosinophilia with elevated liver enzymes up to 3–4 times the upper limit of normal (1 patient, 5.3 %). Conclusions. Dupilumab therapy over 12 weeks leads to the achievement of clinical (63.2 %) and histological (94.7 %) remission in eosinophilic esophagitis.
- 5 September 2026
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 36 (4) , 55-66
Open AccessBiological Therapy for Complicated Forms of Eosinophilic Esophagitis
Aim: to evaluate the efficacy and safety of dupilumab, a biologic therapy, in the treatment of refractory eosinophilic esophagitis complicated by esophageal strictures and food impaction, in patients who have failed prior therapy with proton pump inhibitors and topical glucocorticosteroids. Materials and methods. In a prospective study conducted from July 2024 to February 2026, 19 patients (2 females, 17 males) aged 19 to 70 years with a previously confirmed diagnosis of eosinophilic esophagitis were administered dupilumab at a dose of 300 mg once weekly subcutaneously for 12 weeks. Indications for dupilumab administration included a complicated disease course (esophageal strictures and narrowing, esophageal dissection, recurrent episodes of acute food impaction) in the setting of resistance to prior therapy with topical glucocorticosteroids and/or proton pump inhibitors. Additional criteria for initiating biologic therapy included coexisting T2-associated diseases, such as bronchial asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. All patients underwent assessment of dysphagia severity according to the Dysphagia Symptom Questionnaire (DSQ), calculation of the clinical and morphological disease activity index, esophagogastroduodenoscopy with esophageal biopsy (at least 6 biopsy specimens from the distal and middle/proximal esophagus), and histopathological examination of biopsy specimens both prior to treatment and at 12 weeks of therapy. Results. At 12 weeks of dupilumab therapy, complete resolution of dysphagia was observed in 9 (75 %) of 12 patients with dysphagia at baseline, and clinical remission (absence of any complaints) was achieved in 12 (63.2 %) of 19 patients. The mean DSQ score, reflecting dysphagia severity, decreased from 32.01 to 7.12 (p < 0.05). Endoscopic disease activity, as assessed by the EREхFS score, decreased from 5.0 [4.0; 7.0] to 1.0 [1.0; 3.0] points (p < 0.0001). Although the proportion of patients with strictures did not change significantly, an increase in esophageal diameter at the stricture site was observed (from 13.1 ± 5.8 mm to 16.1 ± 2.0 mm; p < 0.05). Histological remission (< 15 eosinophils per HPF, ×400) was achieved in 18 (94.7 %) of 19 patients. Adverse events included upper extremity joint pain (1 patient, 5.3 %), conjunctival dryness (2 patients, 10.5 %), and peripheral blood eosinophilia with elevated liver enzymes up to 3–4 times the upper limit of normal (1 patient, 5.3 %). Conclusions. Dupilumab therapy over 12 weeks leads to the achievement of clinical (63.2 %) and histological (94.7 %) remission in eosinophilic esophagitis.
- Open Access
- 23 July 2026
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 23 (3) , 220-251
Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis
This article presents an analysis of current clinical guidelines for the management of patients with eosinophilic esophagitis (EoE) — a chronic immune-mediated disease of the esophagus characterized by eosinophilic infiltration of the mucosa (≥ 15 eos/hpf) and clinical manifestations of esophageal dysfunction. The review highlights key changes in diagnostic approaches and discusses contemporary treatment strategies, including dietary therapy (starting with the least restrictive diets), pharmacological treatment (proton pump inhibitors, topical steroids, biologic therapy), and endoscopic dilation for strictures. The authors emphasize the need for comprehensive monitoring (clinical, endoscopic, and histological) to assess treatment response and for long-term maintenance therapy given the chronic nature of the disease. Special attention is paid to pediatric aspects of patient management.
- 23 July 2026
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 23 (3) , 220-251
Open AccessCurrent Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis
This article presents an analysis of current clinical guidelines for the management of patients with eosinophilic esophagitis (EoE) — a chronic immune-mediated disease of the esophagus characterized by eosinophilic infiltration of the mucosa (≥ 15 eos/hpf) and clinical manifestations of esophageal dysfunction. The review highlights key changes in diagnostic approaches and discusses contemporary treatment strategies, including dietary therapy (starting with the least restrictive diets), pharmacological treatment (proton pump inhibitors, topical steroids, biologic therapy), and endoscopic dilation for strictures. The authors emphasize the need for comprehensive monitoring (clinical, endoscopic, and histological) to assess treatment response and for long-term maintenance therapy given the chronic nature of the disease. Special attention is paid to pediatric aspects of patient management.
- 20 June 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (4)
Clinical and morphological characteristics of eosinophilic esophagitis with surgical complications
Objective. To study the clinical, laboratory, endoscopic, and pathomorphological features of eosinophilic esophagitis with surgical complications. Material and methods. 113 patients with a confirmed eosinophilic esophagitis (based on esophagogastroduodenoscopy with esophageal biopsy) underwent a comprehensive examination including assessment of complaints, medical history, comorbidities, and nutritional status. Laboratory blood tests, esophagogastroduodenoscopy with endocytoscopy and esophageal biopsy, and pathomorphological examination of biopsy specimens were performed. Some patients also underwent barium esophagogram. Results. Complications leading to endoscopic and/or surgical interventions were recorded in 27.4% of patients with eosinophilic esophagitis. Complicated forms of eosinophilic esophagitis were characterized by more severe clinical manifestations (dysphagia and food impaction were observed in 96.7% of patients), changes in laboratory tests (blood eosinophilia and elevated IgE level), a high score on the EREхFS scale (more than 6 points), detection of strictures during endoscopic examination, and fibrosis in the subepithelial layer upon histopathological examination. Conclusion. One-third of eosinophilic esophagitis cases are complicated, requiring patients to seek urgent endoscopic and surgical care. Most patients with a complicated course are young men under 30 years of age, suffering from persistent dysphagia and recurrent food impaction episodes. Esophagogastroduodenoscopy in patients with eosinophilic esophagitis reveals characteristic signs of mucosal inflammation – edema, exudate, and longitudinal furrows; in cases of delayed diagnosis, rings and strictures are found in the esophagus. To prevent complications, every patient with unexplained dysphagia (especially with episodes of food impaction) should undergo endoscopic examination of the esophagus with multiple biopsies for timely diagnosis and initiation of anti-inflammatory therapy.
- 20 June 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (4)
Clinical and morphological characteristics of eosinophilic esophagitis with surgical complications
Objective. To study the clinical, laboratory, endoscopic, and pathomorphological features of eosinophilic esophagitis with surgical complications. Material and methods. 113 patients with a confirmed eosinophilic esophagitis (based on esophagogastroduodenoscopy with esophageal biopsy) underwent a comprehensive examination including assessment of complaints, medical history, comorbidities, and nutritional status. Laboratory blood tests, esophagogastroduodenoscopy with endocytoscopy and esophageal biopsy, and pathomorphological examination of biopsy specimens were performed. Some patients also underwent barium esophagogram. Results. Complications leading to endoscopic and/or surgical interventions were recorded in 27.4% of patients with eosinophilic esophagitis. Complicated forms of eosinophilic esophagitis were characterized by more severe clinical manifestations (dysphagia and food impaction were observed in 96.7% of patients), changes in laboratory tests (blood eosinophilia and elevated IgE level), a high score on the EREхFS scale (more than 6 points), detection of strictures during endoscopic examination, and fibrosis in the subepithelial layer upon histopathological examination. Conclusion. One-third of eosinophilic esophagitis cases are complicated, requiring patients to seek urgent endoscopic and surgical care. Most patients with a complicated course are young men under 30 years of age, suffering from persistent dysphagia and recurrent food impaction episodes. Esophagogastroduodenoscopy in patients with eosinophilic esophagitis reveals characteristic signs of mucosal inflammation – edema, exudate, and longitudinal furrows; in cases of delayed diagnosis, rings and strictures are found in the esophagus. To prevent complications, every patient with unexplained dysphagia (especially with episodes of food impaction) should undergo endoscopic examination of the esophagus with multiple biopsies for timely diagnosis and initiation of anti-inflammatory therapy.
- 20 February 2026
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 32 (1)
The choice of the method of intraluminal endoscopic treatment of patients with achalasia of the cardia
Background. Among all intraluminal endoscopic treatments for patients with achalasia cardia (AC), endoscopic balloon pneumacardiodilation (EBPD) and peroral endoscopic myotomy (POEM) are the most interesting. Objective. To study and compare immediate and long-term results of EBPD and POEM in patients with AC on the basis of prospective randomized study. Material and methods. The study included 25 patients with AC of the 1st or 2nd types according to Chicago classification, who had the 2nd or 3rd stage of the disease according to B.V. Petrovsky. After detailed examination all patients were divided into two groups by the stratification block randomization method: in group 1 EBPD was performed, in group 2 — POEM. Results. In group 1 11 EBPD were performed, in group 2 — 14 POEM. All interventions were performed without complications. The mean and absolute duration of EBPD, as well as the duration of hospitalization in group 1 (26.4±9.6 min; 50 min; 3.6±0.9 days) were statistically significantly shorter than in group 2 patients who underwent POEM (96.8±49.1 min; 180 min; 7.0±2.1 days) (p<0.01). All interventions resulted in the relief of dysphagia phenomena. According to the results of clinical and instrumental examination after 1 month, no statistical differences were found in patients of both groups. In 12 months after single EBPD recurrence of AC was registered in 45.4% of patients; after POEM no cases of disease recurrence were registered, and endoscopic signs of terminal esophagitis stage A were revealed in 8.3% of cases. Conclusion. EBPD has advantages over POEM according to the results of evaluation of immediate treatment results, similar clinical effect in the nearest period, but it is considerably inferior to POEM with respect to the reduction of clinical symptoms of AC: 12 months after a single EBPD 43.4% of cases of disease recurrence were registered, while no similar observations were made after POEM.
- 20 February 2026
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 32 (1)
The choice of the method of intraluminal endoscopic treatment of patients with achalasia of the cardia
Background. Among all intraluminal endoscopic treatments for patients with achalasia cardia (AC), endoscopic balloon pneumacardiodilation (EBPD) and peroral endoscopic myotomy (POEM) are the most interesting. Objective. To study and compare immediate and long-term results of EBPD and POEM in patients with AC on the basis of prospective randomized study. Material and methods. The study included 25 patients with AC of the 1st or 2nd types according to Chicago classification, who had the 2nd or 3rd stage of the disease according to B.V. Petrovsky. After detailed examination all patients were divided into two groups by the stratification block randomization method: in group 1 EBPD was performed, in group 2 — POEM. Results. In group 1 11 EBPD were performed, in group 2 — 14 POEM. All interventions were performed without complications. The mean and absolute duration of EBPD, as well as the duration of hospitalization in group 1 (26.4±9.6 min; 50 min; 3.6±0.9 days) were statistically significantly shorter than in group 2 patients who underwent POEM (96.8±49.1 min; 180 min; 7.0±2.1 days) (p<0.01). All interventions resulted in the relief of dysphagia phenomena. According to the results of clinical and instrumental examination after 1 month, no statistical differences were found in patients of both groups. In 12 months after single EBPD recurrence of AC was registered in 45.4% of patients; after POEM no cases of disease recurrence were registered, and endoscopic signs of terminal esophagitis stage A were revealed in 8.3% of cases. Conclusion. EBPD has advantages over POEM according to the results of evaluation of immediate treatment results, similar clinical effect in the nearest period, but it is considerably inferior to POEM with respect to the reduction of clinical symptoms of AC: 12 months after a single EBPD 43.4% of cases of disease recurrence were registered, while no similar observations were made after POEM.
- Open Access
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 12-21
Effectiveness of artificial intelligence's system ArtInCol in diagnostic of colorectal neoplasia during colonoscopy: results of multicenter randomised clinical trial
AIM: to evaluate the effectiveness of the Russian artificial intelligence system ArtInCol during routine colonoscopy.PATIENTS AND METHODS: from August to December 2024 a multicenter randomized trial was done and included 4 medical institutions and 1,128 patients. The patients were randomized into colonoscopy groups without AI (n = 547) and colonoscopy group using the ArtInCol artificial intelligence system (n = 581). The data was analyzed according to the “intention-to-treat” and «per protocol» types, with the primary endpoint being the frequency of detection of adenomas.RESULTS: the randomized groups were homogenous in all analyzed variables. When comparing the primary end-point, the detection rate of adenomas (ADR) in the studied group of AI-assisted colonoscopy was 47.2% (95% CI: 43.1–51.2), compared with 41.3% (95% CI: 37.3–45.5) without AI, the effect value was 5.9%, p = 0.048. The average number of detected adenomas was 0.97 (95% CI: 0.85–1.09), versus 0.79 (95% CI: 0.67–0.92) in the control group, which is a statistically significant difference (p = 0.01).CONCLUSION: the study confirm the hypothesis of the effectiveness of the AI — ArtInCol system in order to improve the quality of neoplasm detection during colonoscopy. An increase in the detection rate of adenomas by 5.9% was recorded.
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 12-21
Open AccessEffectiveness of artificial intelligence's system ArtInCol in diagnostic of colorectal neoplasia during colonoscopy: results of multicenter randomised clinical trial
AIM: to evaluate the effectiveness of the Russian artificial intelligence system ArtInCol during routine colonoscopy.PATIENTS AND METHODS: from August to December 2024 a multicenter randomized trial was done and included 4 medical institutions and 1,128 patients. The patients were randomized into colonoscopy groups without AI (n = 547) and colonoscopy group using the ArtInCol artificial intelligence system (n = 581). The data was analyzed according to the “intention-to-treat” and «per protocol» types, with the primary endpoint being the frequency of detection of adenomas.RESULTS: the randomized groups were homogenous in all analyzed variables. When comparing the primary end-point, the detection rate of adenomas (ADR) in the studied group of AI-assisted colonoscopy was 47.2% (95% CI: 43.1–51.2), compared with 41.3% (95% CI: 37.3–45.5) without AI, the effect value was 5.9%, p = 0.048. The average number of detected adenomas was 0.97 (95% CI: 0.85–1.09), versus 0.79 (95% CI: 0.67–0.92) in the control group, which is a statistically significant difference (p = 0.01).CONCLUSION: the study confirm the hypothesis of the effectiveness of the AI — ArtInCol system in order to improve the quality of neoplasm detection during colonoscopy. An increase in the detection rate of adenomas by 5.9% was recorded.
- Open Access
- 25 June 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (2) , 18-36
Endoscopic Features of Eosinophilic Esophagitis: From Its Origins to Current Practice and Innovations. Literature Review and Personal Experience
Aim: to systematize literature data and the authors’ own findings regarding the endoscopic features of eosinophilic esophagitis.Key points. Eosinophilic esophagitis is a chronic inflammatory disease of the esophagus characterized by marked eosinophilic infiltration of the esophageal mucosa, as well as subepithelial and submucosal fibrosis. These changes lead to functional impairment of the esophagus, stricture formation, and luminal narrowing, clinically manifesting as progressive dysphagia and episodes of luminal obstruction by a food bolus. Timely diagnosis and appropriate treatment of eosinophilic esophagitis help prevent the development of strictures and other complications.The diagnosis relies on endoscopic evaluation with the procurement of multiple biopsies (at least six) from the esophageal mucosa to confirm a characteristic histological picture. The main and additional endoscopic findings in eosinophilic esophagitis include edema, linear furrows, rings, exudates, strictures, so-called “feline” esophagus, narrow-caliber esophagus, and the “crepe-paper” esophagus. In recent years, new endoscopic signs have been proposed, such as multiple polypoid lesions, esophageal changes resembling “ankylosaur back” and a “caterpillar track” pattern. Despite the range of possible endoscopic findings, they exhibit relatively low specificity and may be overlooked by endoscopists, leading to delayed diagnosis. High-resolution endoscopic equipment and the development of artificial intelligence programs for image processing hold promise in improving diagnostic accuracy.Conclusion. Esophagogastroduodenoscopy is the key method for diagnosing eosinophilic esophagitis: awareness of the disease’s endoscopic signs and taking multiple biopsies from the esophagus when eosinophilic esophagitis is suspected allow early diagnosis — prior to the onset of complications — thereby enabling timely treatment to prevent stricture formation.
- 25 June 2025
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 35 (2) , 18-36
Open AccessEndoscopic Features of Eosinophilic Esophagitis: From Its Origins to Current Practice and Innovations. Literature Review and Personal Experience
Aim: to systematize literature data and the authors’ own findings regarding the endoscopic features of eosinophilic esophagitis.Key points. Eosinophilic esophagitis is a chronic inflammatory disease of the esophagus characterized by marked eosinophilic infiltration of the esophageal mucosa, as well as subepithelial and submucosal fibrosis. These changes lead to functional impairment of the esophagus, stricture formation, and luminal narrowing, clinically manifesting as progressive dysphagia and episodes of luminal obstruction by a food bolus. Timely diagnosis and appropriate treatment of eosinophilic esophagitis help prevent the development of strictures and other complications.The diagnosis relies on endoscopic evaluation with the procurement of multiple biopsies (at least six) from the esophageal mucosa to confirm a characteristic histological picture. The main and additional endoscopic findings in eosinophilic esophagitis include edema, linear furrows, rings, exudates, strictures, so-called “feline” esophagus, narrow-caliber esophagus, and the “crepe-paper” esophagus. In recent years, new endoscopic signs have been proposed, such as multiple polypoid lesions, esophageal changes resembling “ankylosaur back” and a “caterpillar track” pattern. Despite the range of possible endoscopic findings, they exhibit relatively low specificity and may be overlooked by endoscopists, leading to delayed diagnosis. High-resolution endoscopic equipment and the development of artificial intelligence programs for image processing hold promise in improving diagnostic accuracy.Conclusion. Esophagogastroduodenoscopy is the key method for diagnosing eosinophilic esophagitis: awareness of the disease’s endoscopic signs and taking multiple biopsies from the esophagus when eosinophilic esophagitis is suspected allow early diagnosis — prior to the onset of complications — thereby enabling timely treatment to prevent stricture formation.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 11 (3)
Endoscopic vs optical biopsy for patients with colorectal lesions: prospective multicentral trial
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить значение эндоскопической и «оптической биопсии» при поверхностных колоректальных эпителиальных новообразованиях. МАТЕРИАЛ И МЕТОДЫ В исследование включены 207 пациентов с 258 новообразованиями. Выполнено сравнение результатов щипцовой биопсии и «оптической» (визуальная характеристика рисунка поверхности новообразований) биопсии в оценке морфологического строения образования, а также проведен анализ влияния полученных результатов на тактику ведения пациента. РЕЗУЛЬТАТЫ Эндоскопическая биопсия — 80 (31%) случаев расхождения с окончательным морфологическим диагнозом, «оптическая» — 98 (38%), p=0,11. В 58 (22,5%) наблюдениях результаты эндоскопической щипцовой биопсии привели бы к ошибочной тактике ведения пациента; результаты «оптической» — в 49 (19,4%) наблюдениях, p=0,32. ЗАКЛЮЧЕНИЕ «Оптическая биопсия» имеет сопоставимые с эндоскопической щипцовой биопсией диагностическую ценность и влияние на выбор дальнейшей тактики ведения пациента.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 11 (3)
Endoscopic vs optical biopsy for patients with colorectal lesions: prospective multicentral trial
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить значение эндоскопической и «оптической биопсии» при поверхностных колоректальных эпителиальных новообразованиях. МАТЕРИАЛ И МЕТОДЫ В исследование включены 207 пациентов с 258 новообразованиями. Выполнено сравнение результатов щипцовой биопсии и «оптической» (визуальная характеристика рисунка поверхности новообразований) биопсии в оценке морфологического строения образования, а также проведен анализ влияния полученных результатов на тактику ведения пациента. РЕЗУЛЬТАТЫ Эндоскопическая биопсия — 80 (31%) случаев расхождения с окончательным морфологическим диагнозом, «оптическая» — 98 (38%), p=0,11. В 58 (22,5%) наблюдениях результаты эндоскопической щипцовой биопсии привели бы к ошибочной тактике ведения пациента; результаты «оптической» — в 49 (19,4%) наблюдениях, p=0,32. ЗАКЛЮЧЕНИЕ «Оптическая биопсия» имеет сопоставимые с эндоскопической щипцовой биопсией диагностическую ценность и влияние на выбор дальнейшей тактики ведения пациента.
- 1 January 2016
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 23-29
Surgical treatment of patients with gastrointestinal stromal tumor of the stomach
To evaluate objectively the effectiveness of currently used diagnostic and curative approaches to gastrointestinal stromal tumors (GIST). Early and remote results of treatment of 49 patients with gastric GISTs were presented. Herewith in 20 (40.8%) patients the disease was complicated by gastrointestinal bleeding. 43 (87.7%) of 49 patients with gastric GIST were operated. Conventional surgery was performed in 24 (55.8%) cases, laparoscopic interventions - in 12 (28%) cases, endoscopic endoluminal - in 7 (16.2%). 6 (14.2%) patients were not operated. Intraoperative complications were observed in 2 (4.65%) patients. In postoperative period complications occurred also in 2 (4.65%) patients. In long-term postoperative period tumoral process progression was observed in 3 (8.3%) patients. Recurrence was diagnosed in 2 (5.6%) patients.
- 1 January 2016
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 23-29
Surgical treatment of patients with gastrointestinal stromal tumor of the stomach
To evaluate objectively the effectiveness of currently used diagnostic and curative approaches to gastrointestinal stromal tumors (GIST). Early and remote results of treatment of 49 patients with gastric GISTs were presented. Herewith in 20 (40.8%) patients the disease was complicated by gastrointestinal bleeding. 43 (87.7%) of 49 patients with gastric GIST were operated. Conventional surgery was performed in 24 (55.8%) cases, laparoscopic interventions - in 12 (28%) cases, endoscopic endoluminal - in 7 (16.2%). 6 (14.2%) patients were not operated. Intraoperative complications were observed in 2 (4.65%) patients. In postoperative period complications occurred also in 2 (4.65%) patients. In long-term postoperative period tumoral process progression was observed in 3 (8.3%) patients. Recurrence was diagnosed in 2 (5.6%) patients.
- 19 December 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (6) , 1278
Submucosal double-tunnel endoscopic resection of the esophageal leiomyoma
- 19 December 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (6) , 1278
Submucosal double-tunnel endoscopic resection of the esophageal leiomyoma